P27kip1 promotes invadopodia turnover and invasion through the regulation of the PAK1/cortactin pathway

eLife

Volumn 6, Issue , 2017, Pages

  Jeannot, Pauline ^a,b,c   Nowosad, Ada ^a,b,c   Perchey, Renaudt ^a,b,c   Callot, Caroline ^a,b,c   Bennana, Evangeline ^d   Katsube, Takanori ^e   Mayeux, Patrick ^d   Guillonneau, François ^d   Manenti, Stéphane ^a,b,c   Besson, Arnaud ^a,b,c  

^a CANCER RESEARCH CENTER OF TOULOUSE   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

^c CNRS ERL5294   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CORTACTIN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; P21 ACTIVATED KINASE 1; CTTN PROTEIN, HUMAN; P21 ACTIVATED KINASE; PAK1 PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; CELL INVASION; CELL INVASION ASSAY; CELL MIGRATION; CELL MIGRATION ASSAY; CELL PROLIFERATION; CONTROLLED STUDY; FIBROBLAST; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOPRECIPITATION; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; NONHUMAN; PODOSOME; PROTEIN DEGRADATION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SEQUENCE ANALYSIS; TRANSCRIPTION REGULATION; WESTERN BLOTTING; ANIMAL; CELL LINE; CELL MOTION; METABOLISM; MOUSE;

ANIMALS; CELL LINE; CELL MOVEMENT; CORTACTIN; CYCLIN-DEPENDENT KINASE INHIBITOR P27; HUMANS; MICE; P21-ACTIVATED KINASES; PODOSOMES;

EID: 85017454871     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.22207     Document Type: Article

References (99)

1. Arthur WT, Burridge K. 2001. RhoA inactivation by p190RhoGAP regulates cell spreading and migration by promoting membrane protrusion and polarity. Molecular Biology of the Cell 12:2711–2720. doi: 10.1091/mbc. 12.9.2711, PMID: 11553710
2. Baldassarre G, Belletti B, Nicoloso MS, Schiappacassi M, Vecchione A, Spessotto P, Morrione A, Canzonieri V, Colombatti A. 2005. p27(Kip1)-stathmin interaction influences sarcoma cell migration and invasion. Cancer Cell 7:51–63. doi: 10.1016/j.ccr.2004.11.025, PMID: 15652749
3. Belletti B, Pellizzari I, Berton S, Fabris L, Wolf K, Lovat F, Schiappacassi M, D’Andrea S, Nicoloso MS, Lovisa S, Sonego M, Defilippi P, Vecchione A, Colombatti A, Friedl P, Baldassarre G. 2010. p27kip1 controls cell morphology and motility by regulating microtubule-dependent lipid raft recycling. Molecular and Cellular Biology 30:2229–2240. doi: 10.1128/MCB.00723-09, PMID: 20194624
4. Besson A, Assoian RK, Roberts JM. 2004a. Regulation of the cytoskeleton: an oncogenic function for CDK inhibitors? Nature Reviews Cancer 4:948–955. doi: 10.1038/nrc1501, PMID: 15573116
5. Besson A, Gurian-West M, Schmidt A, Hall A, Roberts JM. 2004b. p27Kip1 modulates cell migration through the regulation of RhoA activation. Genes & Development 18:862–876. doi: 10.1101/gad.1185504, PMID: 15078817
6. Besson A, Gurian-West M, Chen X, Kelly-Spratt KS, Kemp CJ, Roberts JM. 2006. A pathway in quiescent cells that controls p27Kip1 stability, subcellular localization, and tumor suppression. Genes & Development 20:47– 64. doi: 10.1101/gad.1384406, PMID: 16391232
7. Besson A, Hwang HC, Cicero S, Donovan SL, Gurian-West M, Johnson D, Clurman BE, Dyer MA, Roberts JM. 2007. Discovery of an oncogenic activity in p27Kip1 that causes stem cell expansion and a multiple tumor phenotype. Genes & Development 21:1731–1746. doi: 10.1101/gad.1556607, PMID: 17626791
8. Besson A, Dowdy SF, Roberts JM. 2008. CDK inhibitors: cell cycle regulators and beyond. Developmental Cell 14:159–169. doi: 10.1016/j.devcel.2008.01.013, PMID: 18267085
9. Bian Y, Song C, Cheng K, Dong M, Wang F, Huang J, Sun D, Wang L, Ye M, Zou H. 2014. An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. Journal of Proteomics 96:253–262. doi: 10.1016/j.jprot.2013.11.014, PMID: 24275569
10. Bisht S, Nolting J, Schütte U, Haarmann J, Jain P, Shah D, Brossart P, Flaherty P, Feldmann G. 2015. Cyclin-Dependent kinase 5 (CDK5) Controls melanoma cell motility, invasiveness, and metastatic Spread-Identification of a promising novel therapeutic target. Translational Oncology 8:295–307. doi: 10.1016/j.tranon.2015.06.002, PMID: 26310376
11. (Kip1) and regulates cell cycle progression. The EMBO Journal 21: 3390–3401. doi: 10.1093/emboj/cdf343, PMID: 12093740
12. Castro-Castro A, Janke C, Montagnac G, Paul-Gilloteaux P, Chavrier P. 2012. ATAT1/MEC-17 acetyltransferase and HDAC6 deacetylase control a balance of acetylation of alpha-tubulin and cortactin and regulate MT1-MMP trafficking and breast tumor cell invasion. European Journal of Cell Biology 91:950–960. doi: 10.1016/j.ejcb. 2012.07.001, PMID: 22902175
13. Chen L, Giorgianni F, Beranova-Giorgianni S. 2010. Characterization of the phosphoproteome in LNCaP prostate Cancer cells by in-gel isoelectric focusing and tandem mass spectrometry. Journal of Proteome Research 9: 174–178. doi: 10.1021/pr900338q, PMID: 20044836
14. Cheng Y, Lu J, Chen G, Ardekani GS, Rotte A, Martinka M, Xu X, McElwee KJ, Zhang G, Zhou Y. 2015. Stage-specific prognostic biomarkers in melanoma. Oncotarget 6:4180–4189. doi: 10.18632/oncotarget.2907, PMID: 25784655
15. Chong C, Tan L, Lim L, Manser E. 2001. The mechanism of PAK activation. autophosphorylation events in both regulatory and kinase domains control activity. Journal of Biological Chemistry 276:17347–17353. doi: 10.1074/jbc.M009316200, PMID: 11278486
16. Chu IM, Hengst L, Slingerland JM. 2008. The cdk inhibitor p27 in human Cancer: prognostic potential and relevance to anticancer therapy. Nature Reviews Cancer 8:253–267. doi: 10.1038/nrc2347, PMID: 18354415
17. Clark ES, Whigham AS, Yarbrough WG, Weaver AM. 2007. Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia. Cancer Research 67:4227– 4235. doi: 10.1158/0008-5472.CAN-06-3928, PMID: 17483334
18. Connor MK, Kotchetkov R, Cariou S, Resch A, Lupetti R, Beniston RG, Melchior F, Hengst L, Slingerland JM. 2003. CRM1/Ran-mediated nuclear export of p27(Kip1) involves a nuclear export signal and links p27 export and proteolysis. Molecular Biology of the Cell 14:201–213. doi: 10.1091/mbc.E02-06-0319, PMID: 12529437
19. Cox EA, Sastry SK, Huttenlocher A. 2001. Integrin-mediated adhesion regulates cell polarity and membrane protrusion through the rho family of GTPases. Molecular Biology of the Cell 12:265–277. doi: 10.1091/mbc.12. 2.265, PMID: 11179414
20. Denicourt C, Saenz CC, Datnow B, Cui XS, Dowdy SF. 2007. Relocalized p27Kip1 tumor suppressor functions as a cytoplasmic metastatic oncogene in melanoma. Cancer Research 67:9238–9243. doi: 10.1158/0008-5472. CAN-07-1375, PMID: 17909030
21. Di Martino J, Henriet E, Ezzoukhry Z, Goetz JG, Moreau V, Saltel F. 2016. The microenvironment controls invadosome plasticity. Journal of Cell Science 129:1759–1768. doi: 10.1242/jcs.182329, PMID: 27029343
22. Fero ML, Rivkin M, Tasch M, Porter P, Carow CE, Firpo E, Polyak K, Tsai LH, Broudy V, Perlmutter RM, Kaushansky K, Roberts JM. 1996. A syndrome of Multiorgan Hyperplasia with features of gigantism, Tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell 85:733–744. doi: 10.1016/S0092-8674(00) 81239-8, PMID: 8646781
23. Fero ML, Randel E, Gurley KE, Roberts JM, Kemp CJ. 1998. The murine gene p27Kip1 is haplo-insufficient for tumour suppression. Nature 396:177–180. doi: 10.1038/24179, PMID: 9823898
24. Friedl P, Wolf K. 2003. Tumour-cell invasion and migration: diversity and escape mechanisms. Nature Reviews Cancer 3:362–374. doi: 10.1038/nrc1075, PMID: 12724734
25. Galea CA, Nourse A, Wang Y, Sivakolundu SG, Heller WT, Kriwacki RW. 2008. Role of intrinsic flexibility in signal transduction mediated by the cell cycle regulator, p27 Kip1. Journal of Molecular Biology 376:827–838. doi: 10.1016/j.jmb.2007.12.016, PMID: 18177895
26. Gao Y, Dickerson JB, Guo F, Zheng J, Zheng Y. 2004. Rational design and characterization of a rac GTPase-specific small molecule inhibitor. PNAS 101:7618–7623. doi: 10.1073/pnas.0307512101, PMID: 15128949
27. Godin JD, Thomas N, Laguesse S, Malinouskaya L, Close P, Malaise O, Purnelle A, Raineteau O, Campbell K, Fero M, Moonen G, Malgrange B, Chariot A, Metin C, Besson A, Nguyen L. 2012. p27(Kip1) is a microtubule-associated protein that promotes microtubule polymerization during neuron migration. Developmental Cell 23: 729–744. doi: 10.1016/j.devcel.2012.08.006, PMID: 23022035
28. Gui P, Labrousse A, Van Goethem E, Besson A, Maridonneau-Parini I, Le Cabec V, Goethem, E VAN, Cabec LE, 2014. Rho/ROCK pathway inhibition by the CDK inhibitor p27(kip1) participates in the onset of macrophage 3D-mesenchymal migration. Journal of Cell Science 127:4009–4023. doi: 10.1242/jcs.150987, PMID: 25015295
29. Hydbring P, Malumbres M, Sicinski P. 2016. Non-canonical functions of cell cycle cyclins and cyclin-dependent kinases. Nature Reviews Molecular Cell Biology 17:280–292. doi: 10.1038/nrm.2016.27, PMID: 27033256
30. Ishida N, Hara T, Kamura T, Yoshida M, Nakayama K, Nakayama KI. 2002. Phosphorylation of p27Kip1 on serine 10 is required for its binding to CRM1 and nuclear export. Journal of Biological Chemistry 277:14355–14358. doi: 10.1074/jbc.C100762200, PMID: 11889117
31. Jeannot P, Callot C, Baer R, Duquesnes N, Guerra C, Guillermet-Guibert J, Bachs O, Besson A. 2015. Loss of p27Kip¹ promotes metaplasia in the pancreas via the regulation of Sox9 expression. Oncotarget 6:35880-35892. doi: 10.18632/oncotarget.5770, PMID: 26416424
32. Jin X, Jin X, Sohn YW, Yin J, Kim SH, Joshi K, Nam DH, Nakano I, Kim H. 2013. Blockade of EGFR signaling promotes glioma stem-like cell invasiveness by abolishing ID3-mediated inhibition of p27(KIP1) and MMP3 expression. Cancer Letters 328:235–242. doi: 10.1016/j.canlet.2012.09.005, PMID: 23022473
33. Kandoth C, McLellan MD, Vandin F, Ye K, Niu B, Lu C, Xie M, Zhang Q, McMichael JF, Wyczalkowski MA, Leiserson MD, Miller CA, Welch JS, Walter MJ, Wendl MC, Ley TJ, Wilson RK, Raphael BJ, Ding L. 2013. Mutational landscape and significance across 12 major Cancer types. Nature 502:333–339. doi: 10.1038/nature12634, PMID: 24132290
34. Katsube T, Togashi S, Hashimoto N, Ogiu T, Tsuji H. 2004. Filamentous actin binding ability of cortactin isoforms is responsible for their cell-cell junctional localization in epithelial cells. Archives of Biochemistry and Biophysics 427:79–90. doi: 10.1016/j.abb.2004.04.015, PMID: 15178490
35. Kawauchi T, Chihama K, Nabeshima Y, Hoshino M. 2006. Cdk5 phosphorylates and stabilizes p27kip1 contributing to actin organization and cortical neuronal migration. Nature Cell Biology 8:17–26. doi: 10.1038/ncb1338, PMID: 16341208
36. Kirkbride KC, Sung BH, Sinha S, Weaver AM. 2011. Cortactin: a multifunctional regulator of cellular invasiveness. Cell Adhesion & Migration 5:187–198. doi: 10.4161/cam.5.2.14773, PMID: 21258212
37. Kiyokawa H, Kineman RD, Manova-Todorova KO, Soares VC, Hoffman ES, Ono M, Khanam D, Hayday AC, Frohman LA, Koff A. 1996. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell 85:721–732. doi: 10.1016/S0092-8674(00)81238-6, PMID: 8646780
38. Klammer M, Kaminski M, Zedler A, Oppermann F, Blencke S, Marx S, Müller S, Tebbe A, Godl K, Schaab C. 2012. Phosphosignature predicts dasatinib response in non-small cell lung Cancer. Molecular & Cellular Proteomics 11:651–668. doi: 10.1074/mcp.M111.016410, PMID: 22617229
39. Lacy ER, Filippov I, Lewis WS, Otieno S, Xiao L, Weiss S, Hengst L, Kriwacki RW. 2004. p27 binds cyclin-CDK complexes through a sequential mechanism involving binding-induced protein folding. Nature Structural & Molecular Biology 11:358–364. doi: 10.1038/nsmb746, PMID: 15024385
40. Lacy ER, Wang Y, Post J, Nourse A, Webb W, Mapelli M, Musacchio A, Siuzdak G, Kriwacki RW. 2005. Molecular basis for the specificity of p27 toward cyclin-dependent kinases that regulate cell division. Journal of Molecular Biology 349:764–773. doi: 10.1016/j.jmb.2005.04.019, PMID: 15890360
41. Larrea MD, Hong F, Wander SA, da Silva TG, Helfman D, Lannigan D, Smith JA, Slingerland JM. 2009. RSK1 drives p27Kip1 phosphorylation at T198 to promote RhoA inhibition and increase cell motility. PNAS 106: 9268–9273. doi: 10.1073/pnas.0805057106, PMID: 19470470
42. Lee MH, Nikolic M, Baptista CA, Lai E, Tsai LH, Massagué J. 1996. The brain-specific activator p35 allows Cdk5 to escape inhibition by p27Kip1 in neurons. PNAS 93:3259–3263. doi: 10.1073/pnas.93.8.3259, PMID: 8622924
43. Li Z, Jiao X, Wang C, Ju X, Lu Y, Yuan L, Lisanti MP, Katiyar S, Pestell RG. 2006. Cyclin D1 induction of cellular migration requires p27(KIP1). Cancer Research 66:9986–9994. doi: 10.1158/0008-5472.CAN-06-1596, PMID: 17047061
44. Li H, Collado M, Villasante A, Matheu A, Lynch CJ, Cañamero M, Rizzoti K, Carneiro C, Martínez G, Vidal A, Lovell-Badge R, Serrano M. 2012. p27(Kip1) directly represses Sox2 during embryonic stem cell differentiation. Cell Stem Cell 11:845–852. doi: 10.1016/j.stem.2012.09.014, PMID: 23217425
45. Liang J, Zubovitz J, Petrocelli T, Kotchetkov R, Connor MK, Han K, Lee JH, Ciarallo S, Catzavelos C, Beniston R, Franssen E, Slingerland JM. 2002. PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nature Medicine 8:1153–1160. doi: 10.1038/nm761, PMID: 12244302
46. Liang J, Shao SH, Xu ZX, Hennessy B, Ding Z, Larrea M, Kondo S, Dumont DJ, Gutterman JU, Walker CL, Slingerland JM, Mills GB. 2007. The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis. Nature Cell Biology 9:218–224. doi: 10.1038/ncb1537, PMID: 17237771
47. Licciulli S, Maksimoska J, Zhou C, Troutman S, Kota S, Liu Q, Duron S, Campbell D, Chernoff J, Field J, Marmorstein R, Kissil JL. 2013. FRAX597, a small molecule inhibitor of the p21-activated kinases, inhibits tumorigenesis of neurofibromatosis type 2 (NF2)-associated schwannomas. Journal of Biological Chemistry 288:29105–29114. doi: 10.1074/jbc.M113.510933, PMID: 23960073
48. Lin TC, Tsai LH, Chou MC, Chen CY, Lee H. 2016. Association of cytoplasmic p27 expression with an unfavorable response to cisplatin-based chemotherapy and poor outcomes in non-small cell lung Cancer. Tumor Biology 37:4017–4023. doi: 10.1007/s13277-015-4272-7, PMID: 26482622
49. Linder S, Wiesner C, Himmel M. 2011. Degrading devices: invadosomes in proteolytic cell invasion. Annual Review of Cell and Developmental Biology 27:185–211. doi: 10.1146/annurev-cellbio-092910-154216, PMID: 21 801014
50. Lu W, Katz S, Gupta R, Mayer BJ. 1997. Activation of pak by membrane localization mediated by an SH3 domain from the adaptor protein nck. Current Biology 7:85–94. doi: 10.1016/S0960-9822(06)00052-2, PMID: 9024622
51. Lu W, Mayer BJ. 1999. Mechanism of activation of Pak1 kinase by membrane localization. Oncogene 18:797– 806. doi: 10.1038/sj.onc.1202361, PMID: 9989831
52. MacGrath SM, Koleske AJ. 2012. Cortactin in cell migration and Cancer at a glance. Journal of Cell Science 125: 1621–1626. doi: 10.1242/jcs.093781, PMID: 22566665
53. Malliri A, Ten KJP, Olivio C, Collard JG. 2000. Determination of the activity of Rho-like GTPases in cells. Methods in Molecular Biology 189:99–109. doi: 10.1385/1-59259-281-3:099
54. Mertins P, Yang F, Liu T, Mani DR, Petyuk VA, Gillette MA, Clauser KR, Qiao JW, Gritsenko MA, Moore RJ, Levine DA, Townsend R, Erdmann-Gilmore P, Snider JE, Davies SR, Ruggles KV, Fenyo D, Kitchens RT, Li S, Olvera N, et al. 2014. Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Molecular & Cellular Proteomics 13:1690–1704. doi: 10. 1074/mcp.M113.036392, PMID: 24719451
55. Mertins P, Mani DR, Ruggles KV, Gillette MA, Clauser KR, Wang P, Wang X, Qiao JW, Cao S, Petralia F, Kawaler E, Mundt F, Krug K, Tu Z, Lei JT, Gatza ML, Wilkerson M, Perou CM, Yellapantula V, Huang KL, et al. 2016. Proteogenomics connects somatic mutations to signalling in breast Cancer. Nature 534:55–62. doi: 10.1038/nature18003, PMID: 27251275
56. Min YH, Cheong JW, Kim JY, Eom JI, Lee ST, Hahn JS, Ko YW, Lee MH. 2004. Cytoplasmic mislocalization of p27Kip1 protein is associated with constitutive phosphorylation of akt or protein kinase B and poor prognosis in acute myelogenous leukemia. Cancer Research 64:5225–5231. doi: 10.1158/0008-5472.CAN-04-0174, PMID: 15289327
57. Moshfegh Y, Bravo-Cordero JJ, Miskolci V, Condeelis J, Hodgson L. 2014. A Trio-Rac1-Pak1 signalling Axis drives invadopodia disassembly. Nature Cell Biology 16:574–586. doi: 10.1038/ncb2972, PMID: 24859002
58. Murphy DA, Courtneidge SA. 2011. The ’ins’ and ’outs’ of podosomes and invadopodia: characteristics, formation and function. Nature Reviews Molecular Cell Biology 12:413–426. doi: 10.1038/nrm3141, PMID: 216 97900
59. Nagahara H, Vocero-Akbani AM, Snyder EL, Ho A, Latham DG, Lissy NA, Becker-Hapak M, Ezhevsky SA, Dowdy SF. 1998. Transduction of full-length TAT fusion proteins into mammalian cells: tat-p27kip1 induces cell migration. Nature Medicine 4:1449–1452. doi: 10.1038/4042, PMID: 9846587
60. Nakayama K, Ishida N, Shirane M, Inomata A, Inoue T, Shishido N, Horii I, Loh DY, Nakayama K. 1996. Mice lacking p27(Kip1) display increased body size, multiple organ Hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85:707–720. doi: 10.1016/S0092-8674(00)81237-4, PMID: 8646779
61. Ndubaku CO, Crawford JJ, Drobnick J, Aliagas I, Campbell D, Dong P, Dornan LM, Duron S, Epler J, Gazzard L, Heise CE, Hoeflich KP, Jakubiak D, La H, Lee W, Lin B, Lyssikatos JP, Maksimoska J, Marmorstein R, Murray LJ, et al. 2015. Design of selective PAK1 inhibitor G-5555: improving properties by employing an unorthodox Low-pK a polar moiety. ACS Medicinal Chemistry Letters 6:1241–1246. doi: 10.1021/acsmedchemlett.5b00398, PMID: 26713112
62. Nguyen L, Besson A, Heng JI, Schuurmans C, Teboul L, Parras C, Philpott A, Roberts JM, Guillemot F. 2006. p27kip1 independently promotes neuronal differentiation and migration in the cerebral cortex. Genes & Development 20:1511–1524. doi: 10.1101/gad.377106, PMID: 16705040
63. Nickeleit I, Zender S, Sasse F, Geffers R, Brandes G, Sörensen I, Steinmetz H, Kubicka S, Carlomagno T, Menche D, Gütgemann I, Buer J, Gossler A, Manns MP, Kalesse M, Frank R, Malek NP. 2008. Argyrin a reveals a critical role for the tumor suppressor protein p27(kip1) in mediating antitumor activities in response to proteasome inhibition. Cancer Cell 14:23–35. doi: 10.1016/j.ccr.2008.05.016, PMID: 18598941
64. Olsen JV, Vermeulen M, Santamaria A, Kumar C, Miller ML, Jensen LJ, Gnad F, Cox J, Jensen TS, Nigg EA, Brunak S, Mann M. 2010. Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Science Signaling 3:ra3. doi: 10.1126/scisignal.2000475, PMID: 20068231
65. Ong CC, Gierke S, Pitt C, Sagolla M, Cheng CK, Zhou W, Jubb AM, Strickland L, Schmidt M, Duron SG, Campbell DA, Zheng W, Dehdashti S, Shen M, Yang N, Behnke ML, Huang W, McKew JC, Chernoff J, Forrest WF, et al. 2015. Small molecule inhibition of group I p21-activated kinases in breast Cancer induces apoptosis and potentiates the activity of microtubule stabilizing agents. Breast Cancer Research 17:59. doi: 10.1186/s13058-015-0564-5, PMID: 25902869
66. Oser M, Yamaguchi H, Mader CC, Bravo-Cordero JJ, Arias M, Chen X, Desmarais V, van Rheenen J, Koleske AJ, Condeelis J. 2009. Cortactin regulates cofilin and N-WASp activities to control the stages of invadopodium assembly and maturation. The Journal of Cell Biology 186:571–587. doi: 10.1083/jcb.200812176, PMID: 1 9704022
67. Oser M, Mader CC, Gil-Henn H, Magalhaes M, Bravo-Cordero JJ, Koleske AJ, Condeelis J. 2010. Specific tyrosine phosphorylation sites on cortactin regulate Nck1-dependent actin polymerization in invadopodia. Journal of Cell Science 123:3662–3673. doi: 10.1242/jcs.068163, PMID: 20971703
68. Ou L, Waddell MB, Kriwacki RW. 2012. Mechanism of cell cycle entry mediated by the intrinsically disordered protein p27(Kip1). ACS Chemical Biology 7:678–682. doi: 10.1021/cb200487h, PMID: 22276948
69. Papakonstanti EA, Ridley AJ, Vanhaesebroeck B. 2007. The p110delta isoform of PI 3-kinase negatively controls RhoA and PTEN. The EMBO Journal 26:3050–3061. doi: 10.1038/sj.emboj.7601763, PMID: 17581634
70. Perkins DN, Pappin DJ, Creasy DM, Cottrell JS. 1999. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20:3551–3567. doi: 10.1002/(SICI)15222683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2, PMID: 10612281
71. Petrie RJ, Yamada KM. 2016. Multiple mechanisms of 3D migration: the origins of plasticity. Current Opinion in Cell Biology 42:7–12. doi: 10.1016/j.ceb.2016.03.025, PMID: 27082869
72. Pippa R, Espinosa L, Gundem G, García-Escudero R, Dominguez A, Orlando S, Gallastegui E, Saiz C, Besson A, Pujol MJ, López-Bigas N, Paramio JM, Bigas A, Bachs O. 2012. p27Kip1 represses transcription by direct interaction with p130/E2F4 at the promoters of target genes. Oncogene 31:4207–4220. doi: 10.1038/onc.2011. 582, PMID: 22179826
73. Quintavalle M, Elia L, Price JH, Heynen-Genel S, Courtneidge SA. 2011. A cell-based high-content screening assay reveals activators and inhibitors of Cancer cell invasion. Science Signaling 4:ra49. doi: 10.1126/scisignal. 2002032, PMID: 21791703
74. Ren XD, Kiosses WB, Sieg DJ, Otey CA, Schlaepfer DD, Schwartz MA. 2000. Focal adhesion kinase suppresses rho activity to promote focal adhesion turnover. Journal of Cell Science 113 Pt 20:3637–3678. PMID: 11017 882
75. Rinschen MM, Yu MJ, Wang G, Boja ES, Hoffert JD, Pisitkun T, Knepper MA. 2010. Quantitative phosphoproteomic analysis reveals vasopressin V2-receptor-dependent signaling pathways in renal collecting duct cells. PNAS 107:3882–3887. doi: 10.1073/pnas.0910646107, PMID: 20139300
76. Rodier G, Montagnoli A, Di Marcotullio L, Coulombe P, Draetta GF, Pagano M, Meloche S. 2001. p27 cytoplasmic localization is regulated by phosphorylation on Ser10 and is not a prerequisite for its proteolysis. The EMBO Journal 20:6672–6682. doi: 10.1093/emboj/20.23.6672, PMID: 11726503
77. Spector DL. 1997. Isolation of fibroblasts. Goldman R, Leinwand L. Cells: A Laboratory Manual. New York: Cold Spring Harbor Laboratory Press.
78. Sahai E, Olson MF, Marshall CJ. 2001. Cross-talk between ras and rho signalling pathways in transformation favours proliferation and increased motility. The EMBO Journal 20:755–766. doi: 10.1093/emboj/20.4.755, PMID: 1117 9220
79. Sahai E, Marshall CJ. 2003. Differing modes of tumour cell invasion have distinct requirements for rho/ROCK signalling and extracellular proteolysis. Nature Cell Biology 5:711–719. doi: 10.1038/ncb1019, PMID: 12844144
80. Sander EE, van Delft S, ten Klooster JP, Reid T, van der Kammen RA, Michiels F, Collard JG. 1998. Matrixdependent Tiam1/Rac signaling in epithelial cells promotes either cell-cell adhesion or cell migration and is regulated by phosphatidylinositol 3-kinase. The Journal of Cell Biology 143:1385–1398. doi: 10.1083/jcb.143.5. 1385, PMID: 9832565
81. Seals DF, Azucena EF, Pass I, Tesfay L, Gordon R, Woodrow M, Resau JH, Courtneidge SA, Pass JR, Resau M, J. H. 2005. The adaptor protein Tks5/Fish is required for podosome formation and function, and for the proteasedriven invasion of Cancer cells. Cancer Cell 7:155–165. doi: 10.1016/j.ccr.2005.01.006, PMID: 15710328
82. See WL, Heinberg AR, Holland EC, Resh MD. 2010. p27 deficiency is associated with migration defects in PDGF-expressing gliomas in vivo. Cell Cycle 9:1562–1567. doi: 10.4161/cc.9.8.11259, PMID: 20404478
83. Serres MP, Zlotek-Zlotkiewicz E, Concha C, Gurian-West M, Daburon V, Roberts JM, Besson A. 2011. Cytoplasmic p27 is oncogenic and cooperates with ras both in vivo and in vitro. Oncogene 30:2846–2858. doi: 10.1038/onc.2011.9, PMID: 21317921
84. Serres MP, Kossatz U, Chi Y, Roberts JM, Malek NP, Besson A. 2012. p27(Kip1) controls cytokinesis via the regulation of Citron kinase activation. Journal of Clinical Investigation 122:844–858. doi: 10.1172/JCI60376, PMID: 22293177
85. Sethi N, Kang Y. 2011. Unravelling the complexity of metastasis - molecular understanding and targeted therapies. Nature Reviews Cancer 11:735–748. doi: 10.1038/nrc3125, PMID: 21941285
86. Sharma SS, Pledger WJ. 2016. The non-canonical functions of p27(Kip1) in normal and tumor biology. Cell Cycle 15:1–13. doi: 10.1080/15384101.2016.1157238, PMID: 27082696
87. Shvetsov A, Berkane E, Chereau D, Dominguez R, Reisler E. 2009. The actin-binding domain of cortactin is dynamic and unstructured and affects lateral and longitudinal contacts in F-actin. Cell Motility and the Cytoskeleton 66:90–98. doi: 10.1002/cm.20328, PMID: 19089942
88. Sun Y, Sun J, Lungchukiet P, Quarni W, Yang S, Zhang X, Bai W. 2015. Fe65 suppresses breast Cancer cell migration and invasion through Tip60 mediated cortactin acetylation. Scientific Reports 5:11529. doi: 10.1038/srep11529, PMID: 26166158
89. Vial E, Sahai E, Marshall CJ. 2003. ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility. Cancer Cell 4:67–79. doi: 10.1016/S1535-6108(03)00162-4, PMID: 12892714
90. Vidal C, Geny B, Melle J, Jandrot-Perrus M, Fontenay-Roupie M. 2002. Cdc42/Rac1-dependent activation of the p21-activated kinase (PAK) regulates human platelet lamellipodia spreading: implication of the cortical-actin binding protein cortactin. Blood 100:4462–4469. doi: 10.1182/blood.V100.13.4462, PMID: 12453877
91. Weaver AM, Heuser JE, Karginov AV, Lee WL, Parsons JT, Cooper JA. 2002. Interaction of cortactin and N-WASp with Arp2/3 complex. Current Biology 12:1270–1278. doi: 10.1016/S0960-9822(02)01035-7, PMID: 12176354
92. Webb BA, Eves R, Crawley SW, Zhou S, Côté GP, Mak AS. 2005. PAK1 induces podosome formation in A7r5 vascular smooth muscle cells in a PAK-interacting exchange factor-dependent manner. AJP: Cell Physiology 289:C898–C907. doi: 10.1152/ajpcell.00095.2005, PMID: 15944209
93. Webb BA, Zhou S, Eves R, Shen L, Jia L, Mak AS. 2006. Phosphorylation of cortactin by p21-activated kinase. Archives of Biochemistry and Biophysics 456:183–193. doi: 10.1016/j.abb.2006.06.011, PMID: 16854367
94. Wiśniewski JR, Nagaraj N, Zougman A, Gnad F, Mann M. 2010. Brain phosphoproteome obtained by a FASP-based method reveals plasma membrane protein topology. Journal of Proteome Research 9:3280–3289. doi: 10.1021/pr1002214, PMID: 20415495
95. Wu FY, Wang SE, Sanders ME, Shin I, Rojo F, Baselga J, Arteaga CL. 2006. Reduction of cytosolic p27(Kip1) inhibits Cancer cell motility, survival, and tumorigenicity. Cancer Research 66:2162–2172. doi: 10.1158/0008-5472.CAN-05-3304, PMID: 16489017
96. Yang J, Liao D, Wang Z, Liu F, Wu G. 2011. Mammalian target of rapamycin signaling pathway contributes to glioma progression and patients’ Prognosis. Journal of Surgical Research 168:97–102. doi: 10.1016/j.jss.2009. 06.025
97. Zhang X, Yuan Z, Zhang Y, Yong S, Salas-Burgos A, Koomen J, Olashaw N, Parsons JT, Yang XJ, Dent SR, Yao TP, Lane WS, Seto E. 2007. HDAC6 modulates cell motility by altering the acetylation level of cortactin. Molecular Cell 27:197–213. doi: 10.1016/j.molcel.2007.05.033, PMID: 17643370
98. Zhang Y, Zhang M, Dong H, Yong S, Li X, Olashaw N, Kruk PA, Cheng JQ, Bai W, Chen J, Nicosia SV, Zhang X. 2009. Deacetylation of cortactin by SIRT1 promotes cell migration. Oncogene 28:445–460. doi: 10.1038/onc. 2008.388, PMID: 18850005
99. Zhao D, Besser AH, Wander SA, Sun J, Zhou W, Wang B, Ince T, Durante MA, Guo W, Mills G, Theodorescu D, Slingerland J. 2015. Cytoplasmic p27 promotes epithelial-mesenchymal transition and tumor metastasis via STAT3-mediated Twist1 upregulation. Oncogene 34:5447–5459. doi: 10.1038/onc.2014.473, PMID: 25684140